Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease - Wikidata - wikimedia - TriplyDB

Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease

Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease

http://www.wikidata.org/entity/Q34572608

about

Neuroimaging studies of striatum in cognition part II: Parkinson's disease Relevance of the glutathione system in temporal lobe epilepsy: evidence in human and experimental models Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: possible role of the noradrenergic nervous system Human Bacterial Artificial Chromosome (BAC) Transgenesis Fully Rescues Noradrenergic Function in Dopamine β-Hydroxylase Knockout Mice Noradrenergic Modulation of Cognition in Health and Disease.Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease.New perspectives on catecholaminergic regulation of executive circuits: evidence for independent modulation of prefrontal functions by midbrain dopaminergic and noradrenergic neurons.Rapid eye movement sleep behavior disorder: a window on the emotional world of Parkinson disease.Detection of changes in the locus coeruleus in patients with mild cognitive impairment and Alzheimer's disease: high-resolution fast spin-echo T1-weighted imaging.Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.Evidence for a specialized role of the locus coeruleus noradrenergic system in cortical circuitries and behavioral operations.Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.Lesioning noradrenergic neurons of the locus coeruleus in C57Bl/6 mice with unilateral 6-hydroxydopamine injection, to assess molecular, electrophysiological and biochemical changes in noradrenergic signaling.Sequential Loss of LC Noradrenergic and Dopaminergic Neurons Results in a Correlation of Dopaminergic Neuronal Number to Striatal Dopamine Concentration.Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine A strategy for developing new treatment paradigms for neuropsychiatric and neurocognitive symptoms in Alzheimer's disease.Alzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase Identification and distribution of projections from monoaminergic and cholinergic nuclei to functionally differentiated subregions of prefrontal cortex Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson's Disease Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease.Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia.Neurobiology of cognitive impairment in Parkinson's disease.Advances in non-dopaminergic treatments for Parkinson's disease Potential Similarities in Temporal Lobe Epilepsy and Alzheimer’s Disease: From Clinic to Pathology.Locus coeruleus.Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.Evidence for broad versus segregated projections from cholinergic and noradrenergic nuclei to functionally and anatomically discrete subregions of prefrontal cortex.Differential Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on Motor Behavior and Dopamine Levels at Brain Regions in Three Different Mouse Strains.DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis.Vascular degeneration in Parkinson's disease.Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible?Corticotropin releasing factor dose-dependently modulates excitatory synaptic transmission in the noradrenergic nucleus locus coeruleus.Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease.An evidence base for noradrenergic deficits in Parkinson's disease.A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease.

P2860

Q26779306-5293F529-4868-4771-AC45-BC9B8E49F2FE Q26830615-658E213F-1009-4D97-96E0-22D595E6C6D4 Q27010627-370F6025-3C28-4C46-89FE-F51CEE9137EC Q28115881-78F2389C-A6C1-443C-84FD-BFF433349B13 Q30354689-713CD3EA-0B10-4DEB-97BF-B30A3D1E7893 Q33967306-65F59E60-93FA-4EA2-B3A7-26400362408E Q34423297-F90A7D9E-5153-44B7-9180-BC48BC8F714B Q34887731-26BDA55B-A8C1-481D-9B63-470FBE119E7E Q35509032-3E2D6BCF-A54C-4219-8B82-A1D9F1853DBB Q35624275-978AAE5E-4FED-40EC-878E-38543991480D Q35852918-907A78EF-BBCB-4169-9BCD-5C9981974D20 Q35947523-D609CF04-BE49-4A50-9215-3F41C01011DF Q36060314-5064561F-F339-403F-B7B1-DF17983A58AA Q36366780-9BA0CE92-2333-43E3-9F5C-BE0F589508EF Q36663572-7887A6AE-707A-43D7-BEC3-DAFD02BB67DA Q36768052-BF272774-448F-49EB-AF65-459131ED0DA4 Q37212345-0A22B870-3FE1-4200-BFC9-9792EEBBCD9F Q37265155-5F1DB32C-355D-496F-920A-4340AD4A17CE Q37583405-8656FEAC-3391-4950-AF5A-9CA8D4C5E673 Q37634353-5DDA3AA8-F888-4098-89C9-16B6697E3FC3 Q37955871-EDA8C963-0021-48EC-9004-86C8B07F596C Q38051969-3E7D5387-C30F-4A3D-BD65-47400F50F675 Q38067143-F9989D28-D5CB-4182-AFFC-D490153113F9 Q38218083-C7C1B6D9-142B-4FB7-8FE5-A350A3FB2453 Q38218353-B4B903C8-51B7-432E-9D09-5884D86ACE60 Q39422119-7920D1DC-9FC4-4889-AB95-70BD6819AE6C Q40017984-422AED82-C328-4332-830D-A54B2B36AB8C Q41889003-F59789F9-1909-44DA-B287-0C078442E90B Q43242399-531432E9-0936-48E1-A859-7994F54C6F1A Q47183061-4E4AAB33-A53C-4580-AA4B-62E2E22E5CB0 Q47256703-C646D76C-19BA-4365-A526-24E8B431ADF0 Q48091456-75EBA1FB-928F-4AFE-8CE8-B7249AA399AA Q48155753-44925CFA-2599-4AE1-BA0D-8A077C2264EE Q48332119-82CC04B7-AAC3-497A-BBC5-6B2E64F89FE1 Q48351657-51DA3B0C-A420-4949-BCC3-28F05149E852 Q53684476-99FE30E0-A2F7-402E-A109-F710D6BD5F3F Q55432445-3B699901-EE91-4DB7-89AF-18E2591993EE

P2860

Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease

http://www.wikidata.org/entity/Q34572608

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Differential response of the c ...... isease and Alzheimer's disease

@ast

Differential response of the c ...... isease and Alzheimer's disease

@en

Differential response of the c ...... isease and Alzheimer's disease

@nl

type

label

Differential response of the c ...... isease and Alzheimer's disease

@ast

Differential response of the c ...... isease and Alzheimer's disease

@en

Differential response of the c ...... isease and Alzheimer's disease

@nl

prefLabel

Differential response of the c ...... isease and Alzheimer's disease

@ast

Differential response of the c ...... isease and Alzheimer's disease

@en

Differential response of the c ...... isease and Alzheimer's disease

@nl

P1433

Q34572608-053CEB3D-882B-441D-B6DB-B87B4773BE77

P1476

Q34572608-86E875FC-DAA0-4370-9C8A-36E27ADEC30C

P2093

Q34572608-122747D7-E1A8-408C-98D1-1017FD34D15C

Q34572608-61B08A15-8E91-43FA-8F45-258741A6A81A

Q34572608-6C6EFEF6-7D9F-4C8F-9397-BA3DCAA048A2

Q34572608-71A65194-3CA8-4692-BAE1-004845B40B6E

Q34572608-8AE4D2F8-CACF-49CB-B4C0-1DD2CCB8A936

Q34572608-9C9C5C47-0FD8-4388-B6B9-219563FF6A5B

P2860

Q34572608-06429C1A-CB8E-4E1E-BE28-1BF88A2CAA75

Q34572608-08071413-81F7-49D1-8BF8-99B390CEACCF

Q34572608-09A65A8C-CDA2-4C6F-AB86-57D4BE7D5B1C

Q34572608-0BE4D2A3-E59D-4759-AF69-EEFEB551B0F2

Q34572608-0C15C9FD-D9EC-49D3-9A69-816E96846538

Q34572608-0CD64BEC-819A-4EA2-946D-A8B133CF1421

Q34572608-0CDDDE98-228A-4782-AAF6-60051478C6C1

Q34572608-1149476E-A54C-4D71-B950-D32CD6BDEAF4

Q34572608-1223B6A1-2BC4-4D1E-B5EB-C9B9A9A3ADBD

Q34572608-161876BE-6BAC-4C41-8059-1E1F7C3967D3

P304

Q34572608-2D779E32-83EB-44DB-9910-4780B668DF75

P31

Q34572608-7813E0C5-253F-474C-84E4-D76F0DE016B3

P356

Q34572608-4CE0EEC1-8BEE-414D-AE60-2A0A9458D254

P407

Q34572608-5753A755-99BF-425E-9792-C07712AFB2BC

P478

Q34572608-B1E533BA-E1C2-42F6-9102-11660589B10F

P50

Q34572608-B7237960-0D41-4045-B868-9B295CC0CF93

P577

Q34572608-D71A645D-1349-44A0-9AE6-01709679A776

P5875

Q34572608-D1587667-267E-43CE-A4B7-B98684E4EF6A

P698

Q34572608-22B7E1D8-EC96-4305-9326-E0956E09C90C

P921

Q34572608-3A585AE5-5FD6-4A8C-AAF9-6A0EF8C5E8AC

Q34572608-85536657-AA1A-4909-BBC9-4E5B30D19FDD

P932

Q34572608-64929100-2440-4798-AD47-81D1DB35D9F0

P356

J.BRAINRES.2010.12.015

P1433

P1476

Differential response of the c ...... isease and Alzheimer's disease

@en

P2093

Allyn Franklin

http://www.w3.org/2001/XMLSchema#string

J Lynne Greenup

http://www.w3.org/2001/XMLSchema#string

Murray A Raskind

http://www.w3.org/2001/XMLSchema#string

Pamela J McMillan

http://www.w3.org/2001/XMLSchema#string

Patricia Szot

http://www.w3.org/2001/XMLSchema#string

Sylvia S White

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Staging of brain pathology related to sporadic Parkinson's disease

Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5' alternative splice sites responsible for multiple mRNAs

Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys

The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease

Noradrenaline is essential for mouse fetal development

Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase

Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice

Dementia with Lewy bodies: diagnosis and management.

The role of the locus coeruleus in the development of Parkinson's disease.

P304

240-252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BRAINRES.2010.12.015

http://www.w3.org/2001/XMLSchema#string

P407

P478

1373

http://www.w3.org/2001/XMLSchema#string

P50

James B Leverenz

P577

2010-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49672993

http://www.w3.org/2001/XMLSchema#string

P698

21147074

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

Parkinson's disease

P932

3038670

http://www.w3.org/2001/XMLSchema#string